E-LIB Suche - Ergebnisse für: Wang, Eunice S

1

Treatment of patients with blastic plasmacytoid dendritic c..:

Pemmaraju, Naveen ; Madanat, Yazan F. ; Rizzieri, David...
Leukemia & Lymphoma. 65 (2024) 5 - p. 548-559 , 2024

Link: https://doi.org/10.1080/..

2

A phase 1 study of the irreversible FLT3 inhibitor FF-10101..:

Levis, Mark ; Perl, Alexander ; Schiller, Gary...
Blood Advances. 8 (2024) 10 - p. 2527-2535 , 2024

Link: https://doi.org/10.1182/..

3

Acute leukemia with KMT2A rearrangement: A master of disgui..:

Bawek, Sawyer J. ; Wang, Eunice S. ; Green, Steven D.
Leukemia Research Reports. 21 (2024) - p. 100464 , 2024

Link: https://doi.org/10.1016/..

4

Treatment of Philadelphia Chromosome-Positive Acute Lymphob..:

Baron, Jeffrey ; Pandey, Manu R. ; Griffiths, Elizabeth A..
Leukemia Research Reports. , 2024

Link: https://doi.org/10.1016/..

5

Phase 2 study of add-on parsaclisib for patients with myelo..:

Yacoub, Abdulraheem ; Borate, Uma ; Rampal, Raajit K....
Blood Advances. 8 (2024) 6 - p. 1515-1528 , 2024

Link: https://doi.org/10.1182/..

6

Pivekimab sunirine (IMGN632), a novel CD123-targeting antib..:

Daver, Naval G ; Montesinos, Pau ; DeAngelo, Daniel J...
The Lancet Oncology. 25 (2024) 3 - p. 388-399 , 2024

Link: https://doi.org/10.1016/..

7

Phase 1 dose escalation study of the MDM2 inhibitor miladem..:

DiNardo, Courtney D. ; Olin, Rebecca ; Wang, Eunice S....
Cancer Medicine. 13 (2024) 14 - p. , 2024

Link: https://doi.org/10.1002/..

8

CYAD-01, an autologous NKG2D-based CAR T-cell therapy, in r..:

Sallman, David A ; Kerre, Tessa ; Havelange, Violaine...
The Lancet Haematology. 10 (2023) 3 - p. e191-e202 , 2023

Link: https://doi.org/10.1016/..

9

Acute myeloid leukemia with LRRFIP1::FGFR1 rearrangement an..:

Qian, You-Wen ; Wang, Eunice S. ; Sait, Sheila Jani.
Cancer Genetics. 278-279 (2023) - p. 50-54 , 2023

Link: https://doi.org/10.1016/..

10

AML-303 Tagraxofusp, an Anti-CD123 Therapy, in Patients Wit..:

Pemmaraju, Naveen ; Konopleva, Marina ; Sweet, Kendra...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S288 , 2023

Link: https://doi.org/10.1016/..

11

Spliceosome mutations are associated with clinical response..:

Croucher, Peter J P ; Ridinger, Maya ; Becker, Pamela S....
Annals of Hematology. 102 (2023) 11 - p. 3049-3059 , 2023

Link: https://doi.org/10.1007/..

12

Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory..:

Perl, Alexander E. ; Larson, Richard A. ; Podoltsev, Nikolai A....
Transplantation and Cellular Therapy. 29 (2023) 4 - p. 265.e1-265.e10 , 2023

Link: https://doi.org/10.1016/..

13

Gemtuzumab ozogamicin plus standard induction chemotherapy ..:

Awada, Hassan ; Abdelmalek, Mina ; Cronin, Tara...
Blood Cancer Journal. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

14

POSTER: AML-303 Tagraxofusp, an Anti-CD123 Therapy, in Pati..:

Pemmaraju, Naveen ; Konopleva, Marina ; Sweet, Kendra...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S159 , 2023

Link: https://doi.org/10.1016/..

15

Safety and efficacy of CPX-351 in younger patients (<60 yea..:

Przespolewski, Amanda ; Goldberg, Aaron D. ; Talati, Chetasi...
Blood. 141 (2023) 12 - p. 1489-1493 , 2023

Link: https://doi.org/10.1182/..